Senju C, Nakazawa Y, Oso T, Shimada M, et al. Deep intronic founder mutations identified in the ERCC4/XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum. Proc Natl Acad Sci U S A 2023;120:e2217423120.
PMID: 37364129